Page last updated: 2024-08-16

troglitazone and mhc binding peptide

troglitazone has been researched along with mhc binding peptide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, M; Furukawa, Y; Hasegawa, K; Hirai, M; Kawamura, T; Kita, T; Morimoto, T; Wada, H; Yanazume, T	1

Other Studies

1 other study(ies) available for troglitazone and mhc binding peptide

Article	Year
GATA-6 is involved in PPARgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells. Arteriosclerosis, thrombosis, and vascular biology, 2003, Mar-01, Volume: 23, Issue:3 Topics: Actins; Cell Differentiation; Cells, Cultured; Chromans; Dimethyl Sulfoxide; DNA-Binding Proteins; GATA6 Transcription Factor; Humans; Immunohistochemistry; Muscle, Smooth, Vascular; Oligopeptides; Phenotype; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone	2003

Article

Year

GATA-6 is involved in PPARgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells.

Arteriosclerosis, thrombosis, and vascular biology, 2003, Mar-01, Volume: 23, Issue:3

Topics: Actins; Cell Differentiation; Cells, Cultured; Chromans; Dimethyl Sulfoxide; DNA-Binding Proteins; GATA6 Transcription Factor; Humans; Immunohistochemistry; Muscle, Smooth, Vascular; Oligopeptides; Phenotype; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone

2003